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What is known about the subject
 ► The risks of diving with asthma are unknown, and it 
is therefore debated whether or not individuals with 
asthma should be excluded from diving.
What this study adds to existing knowledge
 ► This study developed an algorithm that increased 
the proportion of individuals with asthma being 
classified as having no medical contraindications to 
scuba diving.
ABSTRACT
Background Asthma may be regarded as a 
contraindication to scuba diving.
Purpose A clinical algorithm to assess fitness to dive 
among individuals with asthma was developed and tested 
prospectively in clinical practice.
Study design Cohort study.
Methods All patients with possible asthma referred to 
Hvidovre Hospital, Denmark, for assessment of fitness to 
dive over a 5- year period (2013–2017) were included. 
Fitness to dive was assessed by case history, spirometry 
and mannitol challenge test. All patients with ≥10% 
decline in forced expiratory volume in 1 s (FEV
1
) (at any 
point during the challenge test) were offered step- up 
asthma therapy and rechallenge after at least 3 months. 
Patients with <10% decline in FEV
1
 after administration of 
a maximum dose of mannitol at the latest challenge were 
classified as having no medical contraindications to scuba 
diving.
Results The study cohort comprised 41 patients (24 men; 
mean age 33 years), of whom 71% and 63% of men and 
women, respectively, were treated with rescue bronchodilator 
and inhaled corticosteroid. After the first mannitol challenge 
test, 21 patients were classified as having no medical 
contraindications to scuba diving, of whom 16 were currently 
prescribed asthma medication. After step- up asthma therapy 
and rechallenge test, an additional seven patients were 
classified as having no medical contraindications to scuba 
diving. Overall, using this clinical algorithm, 28 (68%) of the 
referred patients were finally assessed as having no medical 
contraindications to scuba diving.
Conclusion Using a clinical algorithm with mannitol 
challenge to assess fitness to dive among patients with 
possible asthma and allowing a rechallenge test after step- 
up asthma therapy increased the proportion of individuals 
classified as having no medical contraindications to 
scuba diving. However, as this algorithm has so far not 
been evaluated against actual scuba diving safety, further 
studies are clearly needed before it can be implemented 
with confidence for use in clinical practice.
Clinical relevance An algorithm to assess fitness for 
scuba diving among individuals with possible asthma 
using bronchial challenge test, with the option of step- up 
asthma therapy and rechallenge for reassessment, has 
been developed for clinical use.
InTRoduCTIon
Since the scuba device was invented in the 
1940s, it has been debated whether or not 
asthma should be regarded as a contraindi-
cation to diving due to multiple theoretical 
concerns, one of them that bronchospasm, 
and by that air trapping, can occur while the 
diver is under water. Despite several attempts, 
no studies have reported that diving with 
asthma is indeed a risk factor and therefore 
should be regarded as an absolute contra-
indication.1 At present, there is general 
acceptance, not least in the diving commu-
nity, that probably not all individuals suffering 
from asthma should be excluded from recre-
ational diving. However, there remains no 
consensus on how to assess fitness for recre-
ational scuba diving in clinical practice.2 A 
clinical algorithm has therefore been devel-
oped (by the senior author of this study) at 
Hvidovre Hospital on how to assess fitness to 
dive in candidates with possible asthma, even 
though evidence is at best limited. In line with 
this, the objective of the present study was to 
test this algorithm in clinical practice.
MATeRIAlS And MeThodS
Characteristics of enrolled patients
All patients with asthma or possible asthma 
referred to Hvidovre University Hospital, 
Denmark, for assessment of fitness for recre-
ational scuba diving over a 5- year period 
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(2013–2017) were prospectively included in the present 
study.
Case history was obtained from all patients. Family 
disposition to asthma and allergy, that is, relatives with a 
diagnosis of asthma or allergies, and atopic disease and 
symptoms, including wheezing, dyspnoea, coughing, 
chest tightness, recurrent lower respiratory tract infec-
tions, exercise- induced wheezing, exercise- induced 
cough, night- time respiratory symptoms (coughing or 
wheezing during night- time) and symptoms of rhinitis, 
were recorded together with, if relevant, previous diag-
nosis of asthma and currently prescribed antiasthma 
therapy. Patients were categorised as smokers or never 
smokers, and lifetime tobacco exposure was calculated as 
pack- years (one pack- year=20 cigarettes a day for 1 year).
Methods
Spirometry, and if spirometry revealed signs of airflow 
limitation also bronchodilator reversibility test, measure-
ment of fractional exhaled nitric oxide (F
E
NO) and skin 
prick test were performed as part of the routine work- up 
for patients seen at the respiratory outpatient clinic for 
asthma.
Spirometry
Baseline spirometry included forced vital capacity (FVC) 
and forced expiratory volume in 1 s (FEV
1
) in litres and 
per cent predicted3 and FEV
1
:FVC ratio. Findings from 
the bronchodilator reversibility test were recorded, if 
available.
Fractional exhaled nitric oxide
F
E
NO was measured in all patients prior to the mannitol 
challenge test. F
E
NO levels were measured online (rate 
50 mL/s) with the nitric oxide analyser (NIOX; Aero-
crine, Solna, Sweden) and according to the American 
Thoracic Society guidelines4 and expressed in parts per 
billion (ppb). F
E
NO was reported as the mean of two 
measurements.
Skin prick test
The skin prick test was done with common aeroallergens, 
that is, birch, grass, mugwort, horse, dogs, cats, Dermato-
phagoides pteronyssinus, D. farinae, Aspergillus fumigatus, 
Alternaria iridis and Cladosporium herbarum. Allergens 
were tested together with negative and positive controls, 
read after 15–20 min of application, with a positive result 
defined as a weal ≥3 mm in diameter.5
Mannitol challenge test
Bronchial provocation test with mannitol was performed 
in all included individuals as part of the clinical assessment 
algorithm. The mannitol challenge test was performed 
using a commercially available kit (Aridol/Osmohale) 
with prefilled capsules of mannitol at different doses 
(0–160 mg). The mannitol capsules were administered 
by inhalation in nine doses up to a cumulative dose of 
635 mg (5, 10, 20, 40, 2×40, 4×40, 4×40, 4×40 mg). The 
FEV
1
 recorded after inhalation of a 0 mg placebo capsule 
constituted the value used for calculating the target value, 
that is, 15% decline. A standard mannitol challenge test 
is positive when a 15% decline from baseline in FEV
1
 is 
observed, that is, PD
15
. In this study, however, a positive 
test, that is, being classified as having no medical contra-
indications to scuba diving, was defined as a 10% decline 
from baseline in FEV
1
. The test was stopped when a cumu-
lative dose of 635 mg was reached or if a 10% decline 
from baseline in FEV
1
 was observed, in accordance with 
the guidelines of the Danish Flying and Diving Society.
Patients were told not to take rescue bronchodilators 
(short- acting beta
2
 agonist, SABA) or smoke at least 
6 hours before the test, and if necessary the test was 
rescheduled. Patients were informed to continue using 
all maintenance asthma therapy as prescribed; hence, the 
bronchial challenge test was done on currently prescribed 
maintenance therapy.
Clinical algorithm for assessment of fitness to dive in patients 
with possible asthma
According to the national guideline, individuals with 
<10% decline in FEV
1
 following administration of the 
highest dose in a bronchial challenge test with, for 
example, methacholine or mannitol can be regarded as 
having no medical contraindications to scuba diving.6–8 
The present clinical algorithm applied mannitol chal-
lenge test. The mannitol test is an indirect bronchial 
provocation test which in general is more specific for 
identifying individuals with current airways inflammation 
because it causes release of mediators from inflammatory 
cells in the airways. The mannitol test is one of the more 
indirect tests (others include hypertonic saline, dry- air 
hyperpnoea and exercise) and is applied to this algorithm 
due to ease of use in everyday clinical practice. According 
to the algorithm, all individuals with a decline in FEV
1
 
≥10% were offered rechallenge test with mannitol after 
stepping up their asthma therapy, primarily increasing 
the dose of inhaled corticosteroid (ICS) and/or add- on 
long- acting beta
2
 agonist (LABA), after a minimum of 3 
months. After the rechallenge, individuals with a decline 
in FEV
1
 <10% were classified as having no medical contra-
indications to scuba diving.
Statistical analysis
Data were analysed using SPSS V.23. The results are 
expressed as mean±SD, exact number, percentages 
and OR with 95% CI, as appropriate. Further, when 
comparing the means of the divers having no medical 
contraindications to scuba diving versus those classified 
as having medical contraindications to scuba diving, 
independent samples t- test was used. A p value <0.05 was 
considered significant.
ReSulTS
Baseline characteristics
A total of 41 participants were enrolled in the study (24 
men), with a mean age of 33 years (range 10–69 years). 
Further characteristics are given in table 1.
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Table 1 General characteristics of the 41 patients with 
asthma or possible asthma who had a mannitol challenge 
test as part of their assessment of fitness for recreational 
scuba diving
Characteristics Total (N=41)
Male* 58 (24)
Age (years) 33±14
Body mass index 24.1±3.1
Smoking habits†
  Smokers* 17 (7)
  Pack- years 12±6 (6)
  Never smokers* 61 (25)
Prior asthma diagnosis* 78 (32)
Rhinitis* 41 (17)
Predisposition to asthma* 46 (19)
Predisposition to allergy* 41 (17)
The results are given in mean±SD and number of patients.
*Percentages and number of patients.
†Includes data from 38 of 41 patients.
Figure 1 Symptoms of the 41 patients with asthma or 
possible asthma who had a mannitol challenge test as part 
of their assessment of fitness for recreational scuba diving.
Table 2 Spirometry and exhaled nitric oxide (F
E
NO) in 
41 individuals with asthma and/or symptoms suggesting 
asthma assessed for fitness for recreational scuba diving
Male Female
FEV
1
 (L) 3.41±0.69 3.26±0.46
FEV
1
 (% predicted) 92.4±15.7 98.8±12.8
FVC (L) 4.46±0.95 4.07±0.63
FVC (% predicted) 98.9±12.1 104.4±13.4
FEV
1
:FVC 0.78±0.08 0.80±0.04
F
E
NO (ppb) 42±31 22.9±17.9
The results are given in mean±SD.
F
E
NO, fractional exhaled nitric oxide; FEV
1
, forced expiratory 
volume in 1 s; FVC, forced vital capacity; ppb, parts per billion.
Table 3 Results of initial mannitol challenge test according 
to current asthma therapy and outcome of the challenge 
test
<10% fall in 
FEV
1
; no medical 
contraindications 
to dive (n=21)
>10% fall 
in FEV
1
; 
rechallenge 
offered (n=14)
>10% fall in 
FEV
1
; not 
interested in 
rechallenge, 
unfit to dive 
(n=6)
SABA 14 11 4
ICS (no LABA)
  Low (200–400) 6 3 2
  Medium (>400–800) 2 2 0
  High (>800) 1 0 1
ICS (LABA add- on)
  Low (200–400) 1 2 2
  Medium (>400–800) 2 1 0
  High (>800) 1 0 0
  LABA (no ICS) 1 0 0
  LAMA 0 0 0
FEV
1
, forced expiratory volume in 1 s; ICS, inhaled corticosteroid; 
LABA, long- acting beta
2
 agonist; LAMA, long- acting muscarinic 
antagonist; SABA, short- acting beta
2
 agonist.
All patients were assessed for fitness for recreational 
scuba diving, of whom 28 (68%) reported dyspnoea and 
16 (38%) wheezing (figure 1). Levels of lung function 
and F
E
NO are given in table 2.
A total of 32 (78%) participants had a doctor- diagnosed 
asthma prior to referral for assessment of fitness to dive. 
Of the 41 participants, 29 were at the time of testing 
prescribed SABA, including 2 patients with no diagnosis 
of asthma, and 26 patients (63%) were prescribed main-
tenance therapy with ICS.
Assessment of fitness to dive using the clinical algorithm
First mannitol challenge test
All 41 enrolled participants who had a prior diagnosis of 
asthma or symptoms suggesting asthma had a mannitol 
challenge test. After the first mannitol challenge test, a 
total of 21 individuals had a decline of <10% in FEV
1
 and 
were therefore classified as having no medical contrain-
dications to scuba diving, according to the algorithm. Of 
these, 15 had a prior diagnosis of asthma. All patients 
with a fall of >10% in FEV
1
 were offered step- up asthma 
therapy and a rechallenge test, but six patients did not 
wish to continue and were therefore assessed unfit to 
dive. Further details are given in table 3 and figure 2.
Mannitol challenge test after step-up asthma therapy
The remaining 20 patients were offered step- up asthma 
therapy and rechallenge test. Six patients did not wish to 
continue and were therefore assessed unfit to dive. All 
remaining 14 patients were prescribed a higher dose of 
ICS and 8 patients were also prescribed add- on LABA 
therapy. Details of therapy adjustments before the second 
mannitol challenge test are given in table 4.
At the mannitol rechallenge test, seven patients had 
<10% decline in FEV
1
 and were therefore, according 
to the algorithm, classified as having no medical 
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Figure 2 Flow chart showing the 41 candidates for 
recreational scuba diving tested with a mannitol challenge 
test and offered step- up asthma therapy and rechallenge test 
if there was a fall in FEV
1
 >10% in the first mannitol challenge 
test. Candidates with a fall >10% in the retest were not fit 
for recreational scuba diving, along with candidates not 
interested in the retest. FEV
1
, forced expiratory volume in 1 s.
Table 4 Prescribed asthma therapy at the time of the 
mannitol rechallenge test, according to fitness to dive (n=14)
No medical 
contraindications to 
dive (n=7)
Unfit to dive 
(n=7)
SABA 5 6
ICS
  Low (200–400) 1 2
  Medium (>400–800) 6 4
  High (>800) 0 1
LABA add- on 1 2
LABA was only administered in fixed combination with ICS.
ICS, inhaled corticosteroid; LABA, long- acting beta
2
 agonist; 
SABA, short- acting beta
2
 agonist.
contraindications to scuba diving. Five of these individ-
uals had a prior diagnosis of asthma. The remaining 
seven patients had a decline of ≥10% in FEV
1
 and were 
therefore classified as unfit to dive (figure 2).
Characteristics of individuals with no medical 
contraindications to scuba diving and individuals unfit to dive
Of the 41 patients, 28 (68%) had no medical contrain-
dications to scuba diving, including 20 individuals with a 
prior diagnosis of asthma, leaving 13 individuals (32%) 
unfit to dive, including 1 patient with no prior diagnosis 
of asthma. This patient, however, had the highest level of 
F
E
NO (115.5 ppb) of all participants and was afterwards 
diagnosed with asthma and prescribed asthma therapy. 
The flow of patients is shown in figure 2. When comparing 
individuals with no medical contraindications to scuba 
diving with individuals unfit to dive, no significant differ-
ences were found apart from the level of F
E
NO; that is, 
in patients with no medical contraindications to scuba 
diving, the mean F
E
NO was 22.8±12.4 ppb, compared 
with a mean of 55±36.5 ppb in individuals classified as 
being unfit to dive (p=0.01).
dISCuSSIon
The algorithm used in the present study to assess fitness 
for scuba diving in individuals with asthma, with the 
option of step- up asthma therapy and rechallenge, 
increased the likelihood of being classified as having no 
medical contraindications to scuba diving compared with 
assessments based on current national guidelines.
Comparing national guidelines
There are several published national guidelines around 
the world with different recommendations on how to 
assess diving candidates with asthma.
Strauss9 was the first in 1979 to suggest that contraindi-
cations to diving in subjects with asthma should include 
significant obstructive pulmonary disease with minimal 
values for FEV
1
 and FVC and maximum voluntary venti-
lation of 75% of predicted; any asthma attack occurring 
within the past 2 years; the need for preventive therapy; 
or any episode of bronchospasm associated with exertion 
and/or inhalation of cold air. These contraindications are 
based on theoretical concerns rather than evidence, and 
most guidelines published since then have been based 
on this recommendation. Today, however, most diving 
experts or diving societies have more liberal approaches.
The British Thoracic Society Fitness to Dive Group (a 
subgroup of the British Thoracic Society Standards of 
Care Committee) and the Danish guidelines from the 
Danish Society of Respiratory Medicine share content 
from their respective guidelines and recommend that 
subjects with wheezing precipitated by exercise- induced, 
cold- induced or emotion- induced asthma should be 
excluded from diving, and that subjects with asthma 
should refrain from diving if they have symptoms 
requiring relief medication in the 48 hours preceding the 
dive and if they have reduced fall in peak expiratory flow 
(PEF) >10% from best values or increased peak flow vari-
ability >20% diurnal variation.8 10 Further, according to 
the Danish national guideline from the Flying and Diving 
Medical Society, individuals with >10% decline in FEV
1
 
following administration of the highest dose in a bron-
chial challenge test with, for example, methacholine or 
mannitol are classified as unfit for scuba diving.8
In the USA, the National Institutes of Health in 2016 
published recommendations that allow subjects with well- 
controlled, mild- to- moderate asthma, that is, no current 
chest symptoms and with normal screening spirometry, 
to go scuba diving. The recommendation also states that 
patients with exercise- induced, emotion- induced and 
cold- induced asthma, along with patients with asthma 
requiring rescue medication within 48 hours, should not 
dive. Furthermore, the US recommendations point to 
other diving societies recommending that a patient with 
asthma should successfully pass a bronchial provocation 
challenge.11
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In Australia and New Zealand, the South Pacific Under-
water Medicine Society (SPUMS) recommends that 
candidates who indicate a history of asthma in the last 
10 years and exhibit signs of wheezing or an unexplained 
cough, but have normal spirometry, should have bron-
chial provocation test, using indirect methods including 
dry- air hyperpnoea, exercise and hypertonic challenges 
(saline or mannitol). A positive response, that is, a 
reduction in FEV
1
 of greater than 15%, should lead to a 
recommendation against diving, but does not preclude 
retest and reassessment after asthma control has been 
established. Those who ‘pass’ bronchial provocation tests 
and are taking antiasthma medication should be reas-
sessed annually or sooner if they develop any symptoms. 
It is further recommended that ‘well- controlled’ individ-
uals with asthma, that is, asymptomatic and show normal 
lung function on testing with spirometry and bronchial 
provocation, may be able to dive at an acceptable level of 
risk. All current divers with controlled asthma are strongly 
encouraged to monitor their peak flow twice daily during 
diving periods, with the recommendation to refrain from 
diving if PEF is more than 10% below their best value.12
There is no worldwide consensus on assessment, and 
this is primarily due to the limited evidence. National 
guidelines are mainly based on expert opinions, case 
reports of diving accidents, epidemiological data, anon-
ymous questionnaires, experimental studies with real 
or simulated dives, and annual reports of diving fatali-
ties, injuries and incidents,13–17 and none has generated 
direct evidence that diving with asthma increases the risk 
of misadventure. Future studies should therefore address 
the actual risk related to recreational scuba diving in indi-
viduals with asthma and the impact on the risk of level of 
asthma control, and larger studies using a clinical algo-
rithm that assesses fitness to dive are necessary.
Impact of asthma triggers on fitness to dive
Most experts seem to agree that subjects with exercise- 
induced, cold- induced or emotion- induced asthma 
should be excluded from diving.2 7 18–20 The SPUMS 
guidelines on medical risk assessment for recreational 
diving do not, however, take this aspect into account.12 
The present algorithm is not excluding divers with history 
of wheezing and/or other asthma symptoms triggered 
by exercise, cold or emotion, primarily due to the lack 
of evidence on an association between these symptoms 
and dive- related injuries.21 The concern is that the diving 
environment can be physically challenging and cold and 
trigger anxiety, and therefore cause an asthma attack. It is 
still worth noting that this concern is theoretical and that 
no evidence is indicating that candidates with exercise- 
induced, cold- induced or emotion- induced asthma with 
a negative mannitol challenge test and therefore no 
evidence of airway hyper- responsiveness should not be as 
fit to dive as other patients with asthma. Since there is 
no gold standard on how to assess fitness for recreational 
scuba diving in individuals with asthma or symptoms of 
asthma, this algorithm was developed for use in everyday 
clinical practice, but is limited on safety since it is not 
known whether or not diving with asthma is an actual risk 
factor for injuries.
Future investigations
To know more about potential risks when diving with 
asthma, more studies are needed. Due to ethical 
concerns about performing randomised clinical trials 
in this setting, the use of real- world experience, registry 
data and surveys is the only means to gain insight into the 
risks and recommendations when diving with asthma or 
symptoms of asthma.
Study limitations
The study is limited on safety since there is no evidence 
on how asthma affects recreational scuba diving and 
therefore no gold standard for assessment of fitness to 
dive with asthma.
ConCluSIon
The present study tested a clinical algorithm developed 
at Hvidovre Hospital on how to assess fitness to dive in 
candidates with possible asthma. It showed an increase 
in the proportion of candidates being classified with no 
medical contraindications to scuba diving when mannitol 
challenge test is performed and allowing a rechal-
lenge test after a step- up asthma therapy. However, it is 
important to note that this algorithm has not been evalu-
ated against the actual safety of recreational scuba diving, 
and therefore further studies are clearly needed before 
it can be implemented safely for use in clinical practice.
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